Professor Martin Holke Olof Ugander
Honorary Professor, UNSW (2020)
Fellow of the Cardiac Society of Australia and New Zeeland (2019)
Professor of Cardiac Imaging, University of Sydney (2019)
Associate Professor, Karolinska Institutet, Sweden (2016)
Post-doctoral research fellow, National Institutes of Health (NIH), USA (2009-2011)
PhD, Lund University, Sweden (2006)
MD, Lund University, Sweden (2001
Professor Martin Ugander, MD, PhD, FCSANZ, is an Honorary Professor at St Vincent’s Clinical School, Faculty of Medicine, UNSW, since 2020. He is Professor of Cardiac Imaging at the University of Sydney since 2019. He was born 1975 in Sweden, and grew up in the USA. He received his MD in 2001 and PhD in 2006 from Lund University, Sweden. 2009-2011 he was a Post-doctoral Research Fellow in Cardiovascular MRI and CT at the National Institutes of Health (NIH), USA. 2011-2019 he undertook clinical training in the medical specialty Clinical Physiology at Karolinska University Hospital, Stockholm, Sweden, where he also founded and led the Karolinska Cardiovascular Magnetic Resonance clinical and translational research group at the Karolinska Institute. He continues to hold an affiliation with the Karolinska Institute.
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
Professor Ugander has a research interest in non-invasive cardiac imaging in general and cardiac magnetic resonance imaging (MRI) in particular, with a focus on the diagnoses ischemic heart disease, myocarditis, and heart failure, as well as basic cardiac pumping physiology. His research spans technical, pre-clinical translational, and clinical cardiovascular imaging using cardiac MRI, echocardiography, myocardial perfusion single-photon emission computed tomography (SPECT), x-ray computed tomography (CT), and electrocardiography (ECG).
Our current research specifically focuses on the challenges related to:
- inefficient filling of the heart – diastolic dysfunction,
- thick walls of the heart – left ventricular hypertrophy,
- a reduction in blood flow to the smallest vessels of the heart – coronary microvascular dysfunction,
- how these disease manifestations relate to chest pain and heart failure, in particular heart failure with preserved ejection fraction (HFpEF).